A5032044864- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Pharmacovigilance and Adverse Drug Reactions
- Quality and Safety in Healthcare
- Antiplatelet Therapy and Cardiovascular Diseases
- Nitric Oxide and Endothelin Effects
- Cardiac Imaging and Diagnostics
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Biomedical and Engineering Education
- Cardiac, Anesthesia and Surgical Outcomes
- Lipoproteins and Cardiovascular Health
- Cardiovascular Health and Disease Prevention
Hospital of Prato
2015
University of Florence
1995
Medica (Italy)
1995
This study of seven healthy young subjects was designed both to establish whether endothelin-1 (ET-1) is involved in the homeostasis blood volume and clarify relationship between plasma urinary ET-1. Acute expansion (+17%) caused increases venous pressure (+4.4 mmHg) concentration ET-1 (+129%) a decrease (-99%) excretion Volume depletion (-8.5%) provoked an increase without altering Passive elevation arm resulting local (-17 elicited formation ET-1, with 10-fold venous-arterial gradient...
Age is a major predictor of contrast-induced acute kidney injury (CI-AKI). Few studies have focused on CI-AKI in elderly patients with coronary syndrome (ACS).We compare the incidence <75 and ≥75 years enrolled Protective effect Rosuvastatin Antiplatelet Therapy On myocardial damage ACS (PRATO-ACS) study explore impact high-dose rosuvastatin clinical outcomes 2 age-groups. Statin-naive non-ST-segment elevation scheduled for early invasive strategy (total 504) were randomized to (40 mg...